Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Hyderabad played host to a room full of hard questions as Express Pharma brough...
Prof Dr Debraj Shome, Clinical Scientist and Research Mentor, QR678 opines that...
India’s MSME pharmaceutical manufacturers are facing mounting financial and ope...
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch...
For a long time, Indian pharmaceutical companies could treat trade policy as a ...
As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISC...
HAB Pharma and Signature Phytochemicals have completed a strategic merger throu...
The designation follows two randomised, controlled Phase III trials that showed ...
Helicons are stabilised, cell-penetrant alpha-helical peptides engineered to int...
Parexel, a leading global clinical development partner providing insights-drive...
Glenmark Pharmaceuticals USA announced the launch of Vancomycin Hydrochloride f...
Global pharma major, Lupin announced that it has received tentative approval fr...
Jascayd is said to be the first phosphodiesterase 4B (PDE4B) inhibitor with anti...
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sci...
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian...
Data from the DESTINY-Breast11 and DESTINY-Breast05 Phase III trials support the...
